AMRI CEO to Present at Jefferies 2016 Healthcare Conference
Get Alerts AMRI Hot Sheet
Join SI Premium – FREE
ALBANY, N.Y., May 23, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 at 3:30 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live presentation.
About AMRI Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent and cytotoxic compounds, controlled substances, steroids, hormones, and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-ceo-to-present-at-jefferies-2016-healthcare-conference-300272252.html
SOURCE AMRI
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Lundquist Institute Receives $2.6 Million Grant from U.S. Army Medical Research Acquisition Activity to Develop Wearable Biosensors
- South Florida City Launches Groundbreaking Initiative to Reduce Gun Violence and Foster Peace
- ROSEN, A RANKED AND LEADING FIRM, Encourages Innoviz Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INVZ, INVZW
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!